Stock COH COCHLEAR LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cochlear Limited

Equities

COH

AU000000COH5

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
320.8 AUD +0.24% Intraday chart for Cochlear Limited +1.62% +7.40%
Apr. 22 Cochlear Limited Announces Company Secretary Changes CI
Apr. 19 Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old CI

Evolution of the average Target Price on Cochlear Limited

Price target over the last 5 years

History of analyst recommendation changes

ab.4S5JBgzGoL8LNpWFAoRnCbjC4Qip3QAsbewZKZma2oU.mxcsQlqCwsdAX6LRU6lUc9WRgHrflndLJYBLWOrvvOCVZRA1WvDp8ElnpQ~5911272c711dca3d6c9584081f4c57d4

Analyst Recommendations on Cochlear Limited

Morgan Stanley Adjusts Cochlear’s Price Target to AU$276 From AU$258, Keeps at Underweight MT
Jarden Research Adjusts Cochlear’s Price Target to AU$244.35 From AU$237.17, Keeps at Neutral MT
Australian shares post first weekly fall in three as rate-hike bets back in focus RE
Jarden Research Adjusts Cochlear's Price Target to AU$237.17 From AU$229.20, Keeps at Neutral MT
FTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid Speculation DJ
Rise in UK Rate Expectations Likely to Push Up Mortgage Rates DJ
Sterling May Have Limited Scope to Rise on BOE Rate Expectations DJ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
16
Last Close Price
320.8 AUD
Average target price
280.9 AUD
Spread / Average Target
-12.42%
High Price Target
365 AUD
Spread / Highest target
+13.79%
Low Price Target
220 AUD
Spread / Lowest Target
-31.42%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cochlear Limited

Morgan Stanley
Jarden Research

Ratings for Cochlear Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. COH Stock
  4. Consensus Cochlear Limited